Nicotine and clozapine cross-prime the locus coeruleus noradrenergic system to induce long-lasting potentiation in the rat hippocampus

Hippocampus

Volumn 23, Issue 7, 2013, Pages 616-624

  Rajkumar, Ramamoorthy ^a,b,c   Suri, Sana ^a,b   Min Deng, Hong ^a,b,c   Dawe, Gavin Stewart ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c SINAPSE Singapore Institute for Neurotechnology   (Singapore)

Author keywords

Clozapine; Hippocampus; Long lasting potentiation; Nicotine; Noradrenergic

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; CLOZAPINE; NICOTINE;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; IN VITRO STUDY; LOCUS CERULEUS; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SMOKING; SYNAPSE;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; LOCUS COERULEUS; LONG-TERM POTENTIATION; MALE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879479468     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22122     Document Type: Article

References (63)

1. Abdulla FA, Bradbury E, Calaminici MR, Lippiello PM, Wonnacott S, Gray JA, Sinden JD. 1996. Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology (Berl) 124:323-331.
2. Aghajanian GK, Vandermaelen CP. 1982. Alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: Intracellular studies in vivo. Science 215:1394-1396.
3. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE. 2008. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33:480-490.
4. Bernal MC, Vicens P, Carrasco MC, Redolat R. 1999. Effects of nicotine on spatial learning in C57BL mice. Behav Pharmacol 10:333-336.
5. Berridge CW, Waterhouse BD. 2003. The locus coeruleus noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42:33-84.
6. Bliss TVP, Collingridge GL. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 36:31-39.
7. Bliss TVP, Lomo T. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232:331-356.
8. Brazell MP, Mitchell SN, Gray JA. 1991. Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: A dose-response and antagonist study. Neuropharmacology 30:823-833.
9. Breier A, Elman I, Goldstein DS. 1998. Norepinephrine and schizophrenia: A new hypothesis for antipsychotic drug action. Adv Pharmacol 42:785-788.
10. Brown RA, Walling SG, Milway JS, Harley CW. 2005. Locus coeruleus activation suppresses feedforward interneurons and reduces beta-gamma electroencephalogram frequencies while it enhances theta frequencies in rat dentate gyrus. J Neurosci 25:1985-1991.
11. Brunello N, Masotto C, Steardo L, Markstein R, Racagni G. 1995. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology 13:177-213.
12. Chaulk PC, Harley CW. 1998. Intracerebroventricular norepinephrine potentiation of the perforant path-evoked potential in dentate gyrus of anesthetized and awake rats: A role for both alpha- and beta-adrenoceptor activation. Brain Res 787:59-70.
13. Dahl D, Sarvey JM. 1989. Norepinephrine induces pathway-specific long-lasting potentiation and depression in the hippocampal dentate gyrus. Proc Nat Acad Sci USA 86:4776-4780.
14. Dawe GS, Huff KD, Vandergriff JL, Sharp T, O'Neill MJ, Rasmussen K. 2001. Olanzapine activates the rat locus coeruleus: In vivo electrophysiology and c-Fos immunoreactivity. Biol Psychiatry 50:510-520.
15. Egan TM, North RA. 1986. Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro. Neuroscience 19:565-571.
16. George TP, Sernyak MJ, Ziedonis DM, Woods SW. 1995. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry 56:344-346.
17. Ghosheh OA, Dwoskin LP, Miller DK, Crooks PA. 2001. Accumulation of nicotine and its metabolites in rat brain after intermittent or continuous peripheral administration of [2′-(14)C]nicotine. Drug Metab Dispos 29:645-651.
18. Grant SJ, Redmond DE Jr. 1981. The neuroanatomy and pharmacology of the nucleus locus coeruleus. Prog Clin Biol Res 71:5-27.
19. Grigoryan GA, Gray JA. 1996. A single dose of nicotine proactively enhances the partial reinforcement extinction effect in the rat. Psychobiology 24:136-146.
20. Grinevich VP, Papke RL, Lippiello PM, Bencherif M. 2009. Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors. Neuropharmacology 57:183-191.
21. Hamid S, Dawe GS, Gray JA, Stephenson JD. 1997. Nicotine induces long-lasting potentiation in the dentate gyrus of nicotine-primed rats. Neurosci Res 29:81-85.
22. Harley CW. 1991. Noradrenergic and locus coeruleus modulation of the perforant path evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog Brain Res 88:307-321.
23. Harley CW. 1998. Noradrenergic long-term potentiation in the dentate gyrus. Adv Pharmacol 42:952-956.
24. Harley CW. 2007. Norepinephrine and the dentate gyrus. Prog Brain Res 163:299-318.
25. Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R. 2004. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29:1378-1385.
26. Heishman SJ, Kleykamp BA, Singleton EG. 2010. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 210:453-469.
27. Joseph MH, Peters SL, Prior A, Mitchell SN, Brazel MP Gray JA. 1990. Chronic nicotine administration increases tyrosine hydroxylase selectively in the rat hippocampus. Neurochem Int 16:269-273.
28. Kalkman HO, Loetscher E. 2003. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs. Eur J Pharmacol 462:33-40.
29. Kane JM, Correll CU. 2010. Past and present progress in the pharmacologic treatment of schizophrenia. J Clin Psychiatry 71:1115-1124.
30. Kapur S, VanderSpek SC, Brownlee BA, Nobrega JN. 2003. Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: A suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305: 625-631.
31. Kenney JW, Gould TJ. 2008. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 38:101-121.
32. Kubota T, Jibiki I, Ishikawa A, Kawamura T, Kurokawa S, Wang M. 2008. Increase in extracellular dopamine levels during clozapine-induced potentiation in the hippocampal dentate gyrus of chronically prepared rabbits. Can J Physiol Pharmacol 86:249-256.
33. Kubota T, Jibiki I, Kishizawa S, Kurokawa K. 1996. Clozapine-induced potentiation of synaptic responses in the perforant path-dentate gyrus pathway in chronically prepared rabbits. Neurosci Lett 211:21-24.
34. Lashgari R, Khakpour-Taleghani B, Motamedi F, Shahidi S. 2008. Effects of reversible inactivation of locus coeruleus on long-term potentiation in perforant path-DG synapses in rats. Neurobiol Learn Mem 90:309-316.
35. Leslie FM, Gallardo KA, Park MK. 2002. Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: Direct and indirect mechanisms. Neuropharmacology 42:653-661.
36. Levin ED, Bettegowda C, Weaver T, Christopher NC. 1998. Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 61:335-340.
37. Liao Y, Venhuis BJ, Rodenhuis N, Timmerman W, Wikström H, Meier E, Bartoszyk GD, Böttcher H, Seyfried CA, Sundell S. 1999. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: Chemistry and pharmacological evaluation. J Med Chem 42:2235-2244.
38. Masana M, Bortolozzi A, Artigas F. 2011. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: Therapeutic opportunities in schizophrenia. Int J Neuropsychopharmacol 14:53-68.
39. McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. 1995. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry 37:550-552.
40. McEvoy JP, Freudenreich O, Wilson WH. 1999. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 46:125-129.
41. Mitchell SN, Braze MP, Schugens MM, Gray JA. 1990. Nicotine-induced catecholamine synthesis after lesions to the dorsal or ventral noradrenergic bundle. Eur J Pharmacol 179:383-391.
42. Mitchell SN, Brazell MP, Joseph MH, Alivijeh M, Gray JA. 1989. Regionally specific effects of acute and chronic nicotine on rates of catecholamine and 5-hydroxytryptamine synthesis in rat brain. Eur J Pharmacol 167:311-322.
43. Mitchell SN, Smith KM, Joseph MH, Gray JA. 1993. Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release. Neuroscience 56:989-997.
44. Mitchell SN. 1993. Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology 32:937-949.
45. Neuman RS, Harley CW. 1983. Long-lasting potentiation of the dentate gyrus population spike by norepinephrine. Brain Res 273:162-165.
46. Nilsson LK, Schwieler L, Engberg G, Linderholm KR, Erhardt S. 2005. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: Involvement of glutamatergic mechanisms. Int J Neuropsychopharmacol 8:329-339.
47. Paxinos G, Watson C. 2007. The Rat Brain in Stereotaxic Coordinates, 6th ed. Massachusetts: Elsevier Inc.
48. Pelletier MR, Kirkby RD, Jones SJ, Corcoran ME. 1994. Pathway specificity of noradrenergic plasticity in the dentate gyrus. Hippocampus 4:181-188.
49. Ramirez OA, Wang RY. 1986. Locus coeruleus norepinephrine-containing neurons: Effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine. Brain Res 362:165-170.
50. Reid AT, Harley CW. 2010. An associativity requirement for locus coeruleus-induced long-term potentiation in the dentate gyrus of the urethane-anesthetized rat. Exp Brain Res 200:151-159.
51. Rezvani AH, Caldwell DP, Levin ED. 2006. Chronic nicotine interactions with clozapine and risperidone and attentional function in rats. Prog Neuropsychopharmacol Biol Psychiatry 30:190-197.
52. Segal M, Bloom FE. 1976. The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity. Brain Res 107:513-525.
53. Smith KM, Mitchell SN, Joseph MH. 1991. Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J Neurochem 57:1750-1756.
54. Socci DJ, Sanberg PR, Arendash GW. 1995. Nicotine enhances Morris water maze performance of young and aged rats. Neurobiol Aging 16:857-860.
55. Souto M, Monti JM, Altier H.1979. Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons. Pharmacol Biochem Behav 10:5-9.
56. Tang J, Dani JA. 2009. Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine. Neuron 63:673-682.
57. Verma V, Lim EP, Han SP, Nagarajah R, Dawe GS. 2007. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex. Neurosci Res 57:17-28.
58. Verma V, Rasmussen K, Dawe GS. 2006. Effects of short-term and chronic olanzapine treatment on immediate early gene protein and tyrosine hydroxylase immunoreactivity in the rat locus coeruleus and medial prefrontal cortex. Neuroscience 143:573-585.
59. Washburn M, Moises HC. 1989. Electrophysiological correlates of presynaptic alpha2-receptor-mediated inhibition of norepinephrine release at locus coeruleus synapses in dentate gyrus. J Neurosci 9:2131-2140.
60. Wesnes K, Warburton DM. 1983. Smoking, nicotine and human performance. Pharmacol Ther 21:189-208.
61. Yamazaki Y, Hamaue N, Sumikawa K. 2002. Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction. Brain Res 946:148-152.
62. Yamazaki Y, Jia Y, Hamaue N, Sumikawa K. 2005. Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Eur J Neurosci 22:845-860.
63. Zhang TA, Tang J, Pidoplichko VI, Dani JA. 2010. Addictive nicotine alters local circuit inhibition during the induction of in vivo hippocampal synaptic potentiation. J Neurosci 30:6443-6453.